Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ataru,Igarashi

第一单位： Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

作者： Ataru,Igarashi ^[1] ; Manabu,Akazawa ^[2] ; Tatsunori,Murata ^[3] ; Toshihiko,Taguchi ^[4] ; Alesia,Sadosky ^[5] ; Nozomi,Ebata ^[6] ; Richard,Willke ^[5] ; Koichi,Fujii ^[6] ; Jim,Doherty ^[5] ; Makoto,Kobayashi ^[3]

作者单位： Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. ^[1] Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan. ^[2] CRECON Medical Assessment Inc., Tokyo, Japan. ^[3] Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. ^[4] Pfizer Inc., New York, NY, USA. ^[5] Pfizer Japan, Inc., Tokyo, Japan. ^[6]

关键词 Markov model health economics neuropathic pain quality-adjusted life-year usual care willingness to pay

DOI 10.2147/CEOR.S89833

PMID 26504403

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览65

ClinicoEconomics and outcomes research

2015年7卷

505-20页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

ClinicoEconomics and outcomes research

相似文献

ClinicoEconomics and outcomes research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

ClinicoEconomics and outcomes research

相似文献

ClinicoEconomics and outcomes research

相关期刊

检索历史清除